503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
7.09%
Similar revenue growth to ORCL's 7.74%. Walter Schloss would investigate if similar growth reflects similar quality.
5.77%
Cost growth 1.25-1.5x ORCL's 4.18%. Martin Whitman would scrutinize competitive cost position.
7.24%
Similar gross profit growth to ORCL's 8.80%. Walter Schloss would investigate industry dynamics.
0.14%
Margin expansion below 50% of ORCL's 0.98%. Michael Burry would check for structural issues.
10.05%
R&D growth 50-75% of ORCL's 17.83%. Bruce Berkowitz would examine spending effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.31%
Operating expenses growth 1.1-1.25x ORCL's 7.54%. Bill Ackman would demand justification.
7.90%
Total costs growth 1.1-1.25x ORCL's 6.57%. Bill Ackman would demand justification.
No Data
No Data available this quarter, please select a different quarter.
6.06%
Similar D&A growth to ORCL's 7.83%. Walter Schloss would investigate industry patterns.
5.63%
EBITDA growth below 50% of ORCL's 11.37%. Michael Burry would check for structural issues.
-2.02%
EBITDA margin decline while ORCL shows 3.88% growth. Joel Greenblatt would examine position.
5.58%
Operating income growth below 50% of ORCL's 12.26%. Michael Burry would check for structural issues.
-1.41%
Operating margin decline while ORCL shows 4.19% growth. Joel Greenblatt would examine position.
16.22%
Other expenses growth while ORCL reduces costs. John Neff would investigate differences.
6.28%
Pre-tax income growth 50-75% of ORCL's 11.63%. Martin Whitman would scrutinize operations.
-0.75%
Pre-tax margin decline while ORCL shows 3.61% growth. Joel Greenblatt would examine position.
6.52%
Tax expense growth 50-75% of ORCL's 11.69%. Bruce Berkowitz would examine efficiency.
6.17%
Net income growth 50-75% of ORCL's 11.61%. Martin Whitman would scrutinize operations.
-0.86%
Net margin decline while ORCL shows 3.59% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.17%
Share count increase while ORCL reduces shares. John Neff would investigate differences.
6.17%
Diluted share increase while ORCL reduces shares. John Neff would investigate differences.